Last reviewed · How we verify
NCT06623838: EIC-PP
An Evolutionarily Informed Conceptualization of Personality Pathology
trial testing Evolutionarily informed case conceptualization in Personality Disorder in 110 participants. Currently enrolling.
28 February 2025
Quick facts
| Lead sponsor | Tages Onlus |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 110 |
| Start date | 6 May 2024 |
| Primary completion | 28 February 2025 |
| Estimated completion | 1 April 2025 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Evolutionarily informed case conceptualization
Conditions studied
- Personality Disorder — all drugs for Personality Disorder →
Sponsor
Tages Onlus
Who can join
Eligibility, any sex, with Personality Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to explore the reliability of a new evolutionarily-informed model for conceptualizing personality pathology. In a preliminary phase prior to the present study we investigated reliability by comparing how therapist pairs conceptualized and assessed the same patient and how therapists and patients assessed the acceptability of the model. In this new study we want to confirm that the validity data initially collected are valid across cultures and nations. Therefore, psychology students (n=110) from 5 countries (China, Italy, Poland, Spain, United States) will participate in a specific training on the model and then apply the model on transcripts of the first two sessions and on assessment reports and two supervisors will evaluate the inter-rater reliability and acceptability in using the model on the same patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06623838
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Personality Disorder
Currently open trials in the same condition.
- NCT06993662 — The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective. · Phase 1 · active not recruiting
- NCT06693089 — Metacognitive Interpersonal Therapy Across Transdiagnostic Eating Disorders, Including Underweight · NA · recruiting
Other Tages Onlus trials
Trials by the same sponsor.
- NCT05700786 — Mindful Compassion for Perfectionism · NA · completed
- NCT05710926 — Evolutionary Systems Therapy for Schizotypy · NA · unknown
- NCT04764708 — Compassion and Metacognition in Schizotypal Personality · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06623838 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tages Onlus
- Last refreshed: 2 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06623838.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing